Humacyte Cash Flow Statement (2024-2025) | HUMA

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -27.39M-30.70M-31.76M-29.75M-25.52M-31.44M-26.41M-33.39M
Depreciation and Depletion (Quarter) 1.27M1.30M1.30M1.30M1.30M1.30M1.30M1.34M
Share-based Compensation (Quarter) 1.45M1.44M1.55M1.69M2.49M2.43M2.51M3.13M
Gains from Investment Securities (Quarter) 4.59M25.57M8.49M-1.91M-49.73M5.47M-4.89M-61.63M
Non-cash Items (Quarter) 16.20M7.65M
Cash from Operations (Quarter) -27.35M-21.29M-22.91M-26.58M-28.60M-26.40M-23.90M-26.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.01M0.52M-1.51M0.52M0.52M0.52M0.45M
Depreciation & Amortization (CF) (Quarter) 1.27M1.30M1.30M1.30M1.30M1.30M1.30M1.34M
Change in Working Capital
Change in Receivables (Quarter) 0.31M-0.09M0.68M-0.64M
Change in Inventory (Quarter) 8.02M2.95M7.30M3.56M
Change in Account Payables (Quarter) -2.95M2.31M1.11M-2.44M0.65M1.49M2.99M-4.16M
Change in Accured Expenses (Quarter) -2.11M1.89M2.20M0.26M-2.27M-0.14M0.96M-0.26M
Other Working Capital Changes (Quarter) -0.41M0.13M-0.11M0.34M-0.01M-0.49M0.06M0.97M
Investing Activities
Capital Expenditures (Quarter) 0.03M0.55M0.93M0.06M0.55M0.25M0.05M0.04M
Cash from Investing Activities (Quarter) -0.39M-0.18M-0.93M-0.06M-0.23M-0.57M-0.05M-0.04M
Financing Activities
Other financing activities (Quarter) 0.20M0.10M0.43M
Cash from Financing Activities (Quarter) 62.80M-0.47M0.85M51.01M46.74M2.17M-44.59M57.17M
Additional items
Change in Cash (Quarter) 35.06M-21.94M-22.99M24.37M17.91M-24.82M-68.54M31.01M
Free Cash Flow (Quarter) -27.38M-21.84M-23.84M-26.64M-29.14M-26.65M-23.95M-26.14M
Net Cash Flow (Quarter) 35.06M-21.94M-22.99M24.37M17.91M-24.80M-68.54M31.03M